Focused on Innovative Research
The sequencing of the human genome completed in 2003 launched an era of rapid advancements in genomic medicine – a scientific discipline that uses DNA sequencing and other advanced technologies to determine an individual’s disease risk, diagnosis, and the most effective treatment. Today, scientists and physicians recognize the potential of genomics to revolutionize medical practice by giving clinicians the ability to administer personalized healthcare based in part on an individual’s genotype. Genomics enhances our ability to determine the causes of inherited diseases and advance our understanding of complex disorders, enabling unprecedented new approaches to the diagnosis, treatment, and prevention of both common and rare diseases.
The Center for Genomic Medicine was developed as a collaborative partnership of the University of Alabama at Birmingham School of Medicine and the HudsonAlpha Institute for Biotechnology with the primary mission of conducting research in genomic medicine and facilitating translation of research findings into clinical practice. In support of this mission, the Center brings together multidisciplinary teams from both institutions, comprised of physicians, clinicians, biotechnologists, geneticists, bioinformaticists, and other specialists who engage in collaborative research focused on genomic discoveries that will enhance and inform patient care.
A central goal of the UAB-HudsonAlpha Center for Genomic Medicine (CGM) is to develop and support pilot projects that allow biomedical ...Read More
The Alabama Genomic Health Initiative (AGHI) is one of the first statewide efforts in the country to harness the power of ...Read More
Precision medicine found the right drug for the right patient, helping one UAB prostate cancer patient make a remarkable recovery.Read More
Huntsville, Ala – Recruitment for the Alabama Genomic Health Initiative (AGHI) is underway in Huntsville. The AGHI, a collaboration between the University ...Read More
Huntsville, Ala. – HudsonAlpha Institute for Biotechnology announced today that it has received a $50,000 grant from the Daniel Foundation of ...Read More